IRON TECH(688329)2025-01-16 08:19Financial Performance Forecast - The company expects a net profit attributable to shareholders of the parent company for 2024 to be between -24.31 million RMB and -16.21 million RMB, representing a decrease of 45.73 million RMB to 53.83 million RMB compared to the previous year, a year-on-year decline of 155% to 182%[2][3]. - The net profit attributable to shareholders of the parent company, excluding non-recurring gains and losses, is expected to be between -43.49 million RMB and -29.00 million RMB, a decrease of 46.97 million RMB to 61.46 million RMB compared to the previous year, a year-on-year decline of 261% to 342%[2][3]. - The total profit for the previous year was 34.57 million RMB, with a net profit attributable to shareholders of the parent company of 29.52 million RMB[4]. - There are no significant uncertainties affecting the accuracy of this earnings forecast[6]. - The forecast data is preliminary and subject to change pending the audited financial report for 2024[7]. Expense Impact - The company has increased its investment in sales expenses due to extensive business expansion activities, which has impacted net profit[5]. - The company has also incurred higher management expenses due to depreciation and operational costs associated with the new building[5]. - Significant R&D expenses related to the development of smart traditional Chinese medicine, digital management systems, and medical material management systems have affected net profit[5]. - The company has experienced a decline in software tax rebates due to a decrease in operating income compared to the previous year[5].